CDK8 regulation in alcoholic liver disease

CDK8在酒精性肝病中的调节

• 批准号: 8854005
• 负责人: Fajun James Yang
• 金额: $ 7.44万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-06-01 至 2015-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8854005
• 关键词: ADD-1 protein; Acetylation; Affect; Alcohol abuse; Alcohol consumption; Alcoholic Liver Diseases; Alcohols; Biochemical; Bioinformatics; CDC2 Protein Kinase; Cell Cycle Regulation; Cell Nucleus; Centers for Disease Control and Prevention (U.S.); Cessation of life; Cirrhosis; Complex; Cultured Cells; Cyclin-Dependent Kinases; Data; Development; Disease; Doctor of Philosophy; Down-Regulation; Endoplasmic Reticulum; Ethanol; Ethanol Metabolism; Fatty Liver; Fibrosis; Genes; Genetic Transcription; Glycogen Synthase Kinase 3; Health; Hepatic; Hepatocyte; Histone Deacetylase; Human; In Vitro; Knock-out; Lead; Lipids; Liver; Lysine; MED15; Mediator of activation protein; Membrane; Modification; Molecular; Molecular Biology; Mus; Mutate; N-terminal; Nature; Nuclear; Organ; Outcome; Pharmaceutical Preparations; Phosphorylation; Physiological; Play; Post-Translational Protein Processing; Primary carcinoma of the liver cells; Principal Investigator; Proteins; Proteolytic Processing; Public Health; Recruitment Activity; Regulation; Research; Role; Series; Serum; Site; Staging; Steatohepatitis; Surface; Testing; Therapeutic; Transcription Coactivator; Transcription Factor 3; Translating; United States; Yang; adiponectin; base; chronic alcohol ingestion; citrate carrier; cofactor; cyclin C; effective therapy; fatty acid biosynthesis; human CDK2 protein; human disease; in vivo; in vivo Model; innovation; insight; lipid biosynthesis; liver injury; mouse model; multicatalytic endopeptidase complex; novel; novel therapeutic intervention; problem drinker; protein complex; public health relevance; research study; transcription factor; ubiquitin-protein ligase

DESCRIPTION (provided by applicant): Alcoholic liver disease (ALD) is a leading cause of liver-related deaths in the United States. Currently there is no effective therapy. This is due to the lack of complete mechanistic understanding on how ethanol metabolism causes organ damage. A common feature of ALD is excessive lipid accumulation in hepatocytes, which is driven by alcohol-induced de novo lipogenesis. As a key transcriptional activator of lipogenic genes, sterol regulatory element-binding protein-1c (SREBP-1c) is activated in ALD. Thus, understanding the regulation of SREBP-1c activation will provide not only novel insights into the molecular mechanisms responsible for the development of ALD, but also therapeutic opportunities for treating ALD. Recently, we found CDK8, a subunit of the Mediator cofactor complex, as a negative regulator of de novo lipogenesis. Mechanistically, CDK8 phosphorylates nuclear form of SREBP-1c, promoting degradation of this transcription factor. Interestingly, our preliminary data show that hepatic CDK8 proteins are decreased in mouse models of ALD and in vitro, suggesting that CDK8 is directly or indirectly targeted by ethanol metabolism. However, it is unknown how ethanol down-regulates CDK8. The central hypothesis of the project is that alcohol abuse causes down- regulation of CDK8, and as a result, nuclear SREBP-1c is accumulated, contributing to ALD. To test the hypothesis, a series of in vivo and in vitro experiments are proposed to determine the role of hepatic CDK8 in the development of ALD and to elucidate the regulatory mechanisms of alcohol- induced down-regulation of CDK8. The long-term objective of the project is to determine the function and regulation of CDK8 in ALD. This application is not only significantly relevant to public health, but also highly innovative an will have positive impacts to the field of alcoholic diseases.

描述（由申请人提供）：酒精性肝病（ALD）是美国肝脏相关死亡的主要原因。目前没有有效的治疗方法。这是由于对乙醇代谢如何导致器官损伤缺乏完整的机制理解。ALD的一个共同特征是肝细胞中过量的脂质积聚，这是由酒精诱导的从头脂肪生成驱动的。固醇调节元件结合蛋白-1c（sterol regulatory element-binding protein-1c，SREBP-1c）作为脂肪生成基因的关键转录激活因子，在ALD中被激活。因此，了解SREBP-1c激活的调节不仅将提供对ALD发展的分子机制的新见解，而且还提供治疗ALD的治疗机会。最近，我们发现CDK 8，介体辅因子复合物的一个亚基，作为从头脂肪生成的负调节因子。从机制上讲，CDK 8磷酸化SREBP-1c的核形式，促进该转录因子的降解。有趣的是，我们的初步数据显示，肝脏CDK 8蛋白在ALD小鼠模型和体外降低，表明CDK 8直接或间接被乙醇代谢靶向。然而，尚不清楚乙醇如何下调CDK 8。该项目的中心假设是酒精滥用导致CDK 8下调，结果是核SREBP-1c积累，导致ALD。为了验证这一假设，提出了一系列体内和体外实验来确定肝CDK 8在ALD发展中的作用，并阐明酒精诱导的CDK 8下调的调节机制。该项目的长期目标是确定CDK 8在ALD中的功能和调节。这一应用不仅与公共卫生密切相关，而且具有高度创新性，将对酒精性疾病领域产生积极影响。